Identification of novel α7 nicotinic receptor ligands by in silico screening against the crystal structure of a chimeric α7 receptor ligand binding domain
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Identification of novel α7 nicotinic receptor ligands by in silico screening against the crystal structure of a chimeric α7 receptor ligand binding domain. / Akdemir, Atilla; Edink, Ewald; Thompson, Andrew J.; Lummis, Sarah C.R.; Kooistra, Albert J.; De Graaf, Chris; De Esch, Iwan J.P.
In: Bioorganic and Medicinal Chemistry, Vol. 20, No. 19, 01.10.2012, p. 5992-6002.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Identification of novel α7 nicotinic receptor ligands by in silico screening against the crystal structure of a chimeric α7 receptor ligand binding domain
AU - Akdemir, Atilla
AU - Edink, Ewald
AU - Thompson, Andrew J.
AU - Lummis, Sarah C.R.
AU - Kooistra, Albert J.
AU - De Graaf, Chris
AU - De Esch, Iwan J.P.
PY - 2012/10/1
Y1 - 2012/10/1
N2 - A hierarchical in silico screening procedure using the crystal structure of an agonist bound chimeric α7/Ls-AChBP protein was successfully applied to both proprietary and commercial databases containing drug-like molecules. An overall hit rate of 26% (pKi ≥5.0) was obtained, with an even better hit rate of 35% for the commercial compound collection. Structurally novel and diverse ligands were identified. Binding studies with [ 3H]epibatidine on chimeric α7/5-HT3 receptors yielded submicromolar inhibition constants for identified hits. Compared to a previous screening procedure that utilized the wild type Ls-AChBP crystal structure, the current study shows that the recently obtained α7/Ls-AChBP chimeric protein crystal structure is a better template for the identification of novel α7 receptor ligands.
AB - A hierarchical in silico screening procedure using the crystal structure of an agonist bound chimeric α7/Ls-AChBP protein was successfully applied to both proprietary and commercial databases containing drug-like molecules. An overall hit rate of 26% (pKi ≥5.0) was obtained, with an even better hit rate of 35% for the commercial compound collection. Structurally novel and diverse ligands were identified. Binding studies with [ 3H]epibatidine on chimeric α7/5-HT3 receptors yielded submicromolar inhibition constants for identified hits. Compared to a previous screening procedure that utilized the wild type Ls-AChBP crystal structure, the current study shows that the recently obtained α7/Ls-AChBP chimeric protein crystal structure is a better template for the identification of novel α7 receptor ligands.
KW - α7 Receptor
KW - AChBP
KW - Cys-loop
KW - Docking
KW - In silico screening
KW - nAChR
KW - Virtual screening
UR - http://www.scopus.com/inward/record.url?scp=84866434365&partnerID=8YFLogxK
U2 - 10.1016/j.bmc.2012.06.054
DO - 10.1016/j.bmc.2012.06.054
M3 - Journal article
C2 - 22959526
AN - SCOPUS:84866434365
VL - 20
SP - 5992
EP - 6002
JO - Bioorganic & Medicinal Chemistry
JF - Bioorganic & Medicinal Chemistry
SN - 0968-0896
IS - 19
ER -
ID: 199376408